Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Apr 22;407(4):725-9.
doi: 10.1016/j.bbrc.2011.03.090. Epub 2011 Mar 31.

Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer

Affiliations

Serum amyloid A 2.2 refolds into a octameric oligomer that slowly converts to a more stable hexamer

Yun Wang et al. Biochem Biophys Res Commun. .

Abstract

Serum amyloid A (SAA) is an inflammatory protein predominantly bound to high-density lipoprotein in plasma and presumed to play various biological and pathological roles. We previously found that the murine isoform SAA2.2 exists in aqueous solution as a marginally stable hexamer at 4-20°C, but becomes an intrinsically disordered protein at 37°C. Here we show that when urea-denatured SAA2.2 is dialyzed into buffer (pH 8.0, 4°C), it refolds mostly into an octameric species. The octamer transitions to the hexameric structure upon incubation from days to weeks at 4°C, depending on the SAA2.2 concentration. Thermal denaturation of the octamer and hexamer monitored by circular dichroism showed that the octamer is ∼10°C less stable, with a denaturation mid point of ∼22°C. Thus, SAA2.2 becomes kinetically trapped by refolding into a less stable, but more kinetically accessible octameric species. The ability of SAA2.2 to form different oligomeric species in vitro along with its marginal stability, suggest that the structure of SAA might be modulated in vivo to form different biologically relevant species.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Refolding of SAA2.2 monitored by size-exclusion chromatography (SEC) (A), and analytical ultracentrifugation (AUC) sedimentation equilibrium (SE) analysis of “mature” (B) and “fresh” (C) SAA2.2. Denatured SAA2.2 (0.8 mg/mL, 20 mM Tris, 150 mM NaCl, 6M Urea, pH 8.2) was dialyzed against Tris buffer (20mM Tris, pH 8.2) at 4°C and its oligomeric structure was followed by SEC for 1 month. SAA2.2 refolds initially to an octameric species that later rearranges to a hexamer (A). Representative AUC-SE traces at 10,000 rpm (○), 12,000 rpm (□) and 19,000 rpm (△) for SAA2.2 (20 mM Tris pH 8.2, 150 mM NaCl, 4°C) are shown, where the solid lines represent the global fit of mature (B) and fresh (C) SAA2.2 according to equation 1. The lower panel shows the residuals for each fit. The molecular weight (MW) obtained from the fit for the “mature” and “fresh” protein was 70.5± 0.6 kDa and 85.1± 0.5 kDa, respectively.
Fig. 2
Fig. 2
CD secondary structure characterization (A) and thermal denaturation (B) of SAA2.2 hexamer and octamer. Far-UV CD spectrums of SAA2.2 hexamer (■) and octamer (◆) at 4°C show that they have similar secondary structure. Thermal denaturation curves of SAA2.2 hexamer (■) and octamer (◆) monitored by far-UV CD indicate that the octamer is ~10 °C less stable than the hexamer. Samples contained 0.1 mg/mL SAA2.2 in 20 mM phosphate buffer.
Fig. 3
Fig. 3
Refolding of SAA2.2 (0.8mg/ml in 20mM Tris, 6M Urea, 150mM NaCl, pH 8.2) was performed at room temperature (RT) against Tris buffer (20 mM Tris, pH 8.2). After ~12h ~25μl of the sample was loaded in an analytical gel filtration column to determine the oligomeric state of SAA2.2. A sample from the same SAA2.2 stock was refolded at 4°C as a control, and formed mostly an octamer species.
Fig. 4
Fig. 4
Concentration dependence conversion of SAA2.2 octamer to hexamer. SAA2.2 was purified and dissolved in buffer A (20mM Tris, 6M Urea, 400mM NaCl, pH 8.) and aliquoted at three different concentrations (A: 0.25mg/ml, B: 0.8mg/ml and C: 1.8mg/ml) and allowed to refold at 4°C in for 14hrs in 500 – 1000X refolding buffer (20mM Tris, pH 8). SAA was aliquoted in sterile tubes and stored under refrigerated conditions. At regular intervals (as specified in the figure) samples were analyzed on a Superdex 200® analytical gel filtration column.

Similar articles

Cited by

References

    1. Uhlar CM, Whitehead AS. Serum amyloid A, the major vertebrate acute-phase reactant. Eur J Biochem. 1999;265:501–523. - PubMed
    1. Aldo-Benson MA, Benson MD. SAA suppression of immune response in vitro: evidence for an effect on T cell-macrophage interaction. J Immunol. 1982;128:2390–2392. - PubMed
    1. Steinmetz A, Hocke G, Saile R, Puchois P, Fruchart JC. Influence of serum amyloid A on cholesterol esterification in human plasma. Biochim Biophys Acta. 1989;1006:173–178. - PubMed
    1. Kisilevsky R, Subrahmanyan L. Serum amyloid A changes high density lipoprotein’s cellular affinity. A clue to serum amyloid A’s principal function. Lab Invest. 1992;66:778–785. - PubMed
    1. Liang JS, Schreiber BM, Salmona M, Phillip G, Gonnerman WA, de Beer FC, Sipe JD. Amino terminal region of acute phase, but not constitutive, serum amyloid A (apoSAA) specifically binds and transports cholesterol into aortic smooth muscle and HepG2 cells. J Lipid Res. 1996;37:2109–2116. - PubMed

Publication types

LinkOut - more resources